Nachrichten zur Amgen Inc. Aktie

Amgen Stock Sinks As Market Eyes MariTides Next Move

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after…

Amgen: Solide Zahlen und ein Haar in der Suppe

Amgen hat mit seinen Quartalszahlen positiv überrascht und zugleich die Prognose für das Gesamtjahr 2025 angehoben. Dennoch rutschte die Aktie…

ROUNDUP: Amgen hebt Prognose an - Sorgen um MariTide drücken Kurs

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut gelaufenen Quartal optimistischer…

ROUNDUP: Amgen hebt Prognose an - Sorgen um MariTide drücken Kurs

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut gelaufenen Quartal optimistischer auf 2025. Der Umsatz…

Amgens Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly

Amgen posts strong Q2 beats on earnings and sales, driven by double-digit drug volume gains.…

Earnings call transcript: Amgen beats Q2 2025 earnings expectations By Investing.com

Earnings call transcript: Amgen beats Q2 2025 earnings expectations…

Amgen (AMGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter…

Amgen profit rises, weight-loss data expected in 4th quarter

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales offset…

Amgen hebt Prognose nach überraschend gut verlaufenem Quartal an

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut gelaufenen Quartal optimistischer…

Amgen hebt Prognose nach überraschend gut verlaufenem Quartal an

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut gelaufenen Quartal optimistischer auf 2025. Der Umsatz…

Amgen quarterly results beat Wall Street estimates

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales offset…

Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth

Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Amgen (AMGN) Just Flashed Golden Cross Signal: Do You Buy?

Is it a good or bad thing when a stock experiences a golden cross technical event?…

Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know

Amgen (AMGN) reached $301.29 at the closing of the latest trading day, reflecting a -1.73% change compared to its last…

The Best High-Yield Dividend ETF to Own for the Next 10 Years

Key PointsCompanies must pass key tests to be included in the Schwab U.S. Dividend Equity ETF.This fund has averaged a…

Amgen vs. Novo Nordisk: Which Pharma Giant Is the Better Buy?

AMGNs deep pipeline and rare disease expansion may outweigh NVOs GLP-1 dominance and leadership shakeup.…

Amgen (AMGN) Declines More Than Market: Some Information for Investors

In the latest trading session, Amgen (AMGN) closed at $294.76, marking a -1.17% move from the previous day.…

Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More

…

Dows 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares

The Dow Jones Industrial Average is up Wednesday afternoon with shares of Johnson & Johnson and Amgen seeing positive momentum…

Amgen: Great Starting Yield For This Wealth Compounder

…

How Does Nvidias Reaching $4 Trillion in Market Cap Impact the S&P 500, Nasdaq-100, and Dow Jones?

Key PointsNvidia became the first company to surpass $4 trillion in market cap.A handful of companies can move the Nasdaq-100…

Amgen (AMGN) Falls More Steeply Than Broader Market: What Investors Need to Know

In the latest trading session, Amgen (AMGN) closed at $295.18, marking a -1.73% move from the previous day.…

Amgen: A Defensive Biotech With Yield And Optionality

…

Amgen (AMGN) Advances While Market Declines: Some Information for Investors

Amgen (AMGN) closed the most recent trading day at $297, moving +1.38% from the previous trading session.…

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity

Key PointsWall Streets smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all downside…

Amgen (AMGN) Outperforms Broader Market: What You Need to Know

The latest trading day saw Amgen (AMGN) settling at $296.85, representing a +2.18% change from its previous close.…

Why Amgen Stock Popped by 4% Today

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the…

2 Dividend Stocks to Buy on the Dip and Hold Forever

Over the past year, Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic…

Amgen Looks to Take Share of Booming Obesity Space: Will It Succeed?

Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.…

Amgen (AMGN) Stock Moves 1.03%: What You Should Know

In the most recent trading session, Amgen (AMGN) closed at $280.35, indicating a +1.03% shift from the previous trading day.…

Amgen Inc. (AMGN) Presents at Special Call (IR Call) Conference Transcript

…

Amgen (AMGN) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Amgen (AMGN) closed at $272.44, marking a -5.84% move from the previous day.…

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

Members of Congress Are Pouring Millions Into These 7 Surprising Stocks

In this video, I will review some of the stock purchases made by members of the U.S. Congress. Politicians such…

Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?

Eli Lilly (NYSE: LLY) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical…

Amgen: Imdelltra Data And Q1 Results Impress

…

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

Amgen (AMGN) closed at $297.29 in the latest trading session, marking a +1.88% move from the prior day.…

Amgen Inc. (AMGN) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

…

Why Amgen (AMGN) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

Amgens Strategic Path - Navigating Patent Expiries With Promising New Therapies

…

Amgens Imdelltra Cuts Lung Cancer Death Risk by 40% in Phase III

AMGNs Imdelltra slashes lung cancer death risk by 40% in Phase III, extending survival by over five months compared to…

3 No-Brainer Healthcare Stocks to Buy in June

A new month has arrived. Investors now have a fresh opportunity to buy great stocks. Three Motley Fool contributors believe…

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock…

"If Walmart Is Under Pressure to Raise Prices, Its Going to Have Broader Effects on the Economy."

In this podcast, Motley Fool analyst Tim Beyers and host Ricky Mulvey discuss: Walmarts response to tariff uncertainty. Netflixs booming ad business. How…

The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now

The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&P 500…

Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen

Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace (GE)…

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders…

Amgen Inc. (AMGN) RBC Capital Markets Global Healthcare Conference (Transcript)

…

Amgen Aktie: Chancen in der Pipeline trotz Prolia-Verlust

New York (www.aktiencheck.de) - Amgen-Aktienanalyse von Guggenheim Securities: Vamil Divan, Analyst von Guggenheim Securities, nimmt die Bewertung der Aktie von Amgen…